Human papillomavirus (HPV) vaccine coverage and associated sociodemographic factors among individuals eligible for publicly funded vaccine in Ontario, Canada from 2007 to 2023: A Canadian immunization research network study.

Saved in:
Bibliographic Details
Title: Human papillomavirus (HPV) vaccine coverage and associated sociodemographic factors among individuals eligible for publicly funded vaccine in Ontario, Canada from 2007 to 2023: A Canadian immunization research network study.
Authors: Grewal R; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada. Electronic address: r.grewal@utoronto.ca., Alessandrini J; Public Health Ontario, Toronto, ON, Canada., Wilson SE; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada., Hernandez A; ICES, Toronto, ON, Canada., Basta NE; Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, QC, Canada., Burchell AN; ICES, Toronto, ON, Canada; MAP Centre for Urban Health Solutions, Unity Health Toronto, Toronto, ON, Canada; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada., Deeks SL; Dalhousie University, Halifax, NS, Canada., Lim GH; Public Health Ontario, Toronto, ON, Canada., Navarro C; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada., Ogilvie G; University of British Columbia, Vancouver, BC, Canada., Paul LA; Public Health Ontario, Toronto, ON, Canada., Buchan SA; Centre for Vaccine Preventable Diseases, University of Toronto, Toronto, ON, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada; ICES, Toronto, ON, Canada; Public Health Ontario, Toronto, ON, Canada; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada.
Source: Vaccine [Vaccine] 2026 Mar 19; Vol. 76, pp. 128303. Date of Electronic Publication: 2026 Feb 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-2518
DOI:10.1016/j.vaccine.2026.128303